Chemoinformaics analysis of D-alanine, N-propargyloxycarbonyl-, decyl ester
| Molecular Weight | 311.422 | nRot | 12 |
| Heavy Atom Molecular Weight | 282.19 | nRig | 3 |
| Exact Molecular Weight | 311.21 | nRing | 0 |
| Solubility: LogS | -4.159 | nHRing | 0 |
| Solubility: LogP | 4.249 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 29 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 52.035 |
| nHD | 1 | BPOL | 34.871 |
| QED | 0.341 |
| Synth | 2.769 |
| Natural Product Likeliness | -0.497 |
| NR-PPAR-gamma | 0.018 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.622 |
| MDCK | 0.0000329 |
| BBB | 0.93 |
| PPB | 0.946148 |
| VDSS | 0.937 |
| FU | 0.0206394 |
| CYP1A2-inh | 0.948 |
| CYP1A2-sub | 0.302 |
| CYP2c19-inh | 0.844 |
| CYP2c19-sub | 0.376 |
| CYP2c9-inh | 0.646 |
| CYP2c9-sub | 0.619 |
| CYP2d6-inh | 0.296 |
| CYP2d6-sub | 0.15 |
| CYP3a4-inh | 0.828 |
| CYP3a4-sub | 0.191 |
| CL | 4.402 |
| T12 | 0.37 |
| hERG | 0.085 |
| Ames | 0.038 |
| ROA | 0.069 |
| SkinSen | 0.593 |
| Carcinogencity | 0.176 |
| EI | 0.268 |
| Respiratory | 0.55 |
| NR-Aromatase | 0.245 |
| Antiviral | Yes |
| Prediction | 0.698384 |